Evidence

Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer

The genome sequence of the parasitic amoeba Entamoeba histolytica, a leading cause of severe diarrheal disease in developing countries, includes an unexpectedly complex repertoire of sensory genes as well as a variety of bacterial-like genes that contribute to the organism's unique biology. The report, which appears in the February 24 issue of Nature, presents the first genome-wide study...

Light therapy may combat fungal infections, new evidence suggests

A newly discovered mechanism by which an infectious fungus perceives light also plays an important role in its virulence, according to Howard Hughes Medical Institute investigators at Duke University Medical Center. The findings suggest that changes in light following fungal invasion of the human body may be an important and previously overlooked cue that sparks infection, the researchers said.</...

Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils

Researchers from China and the United States have found evidence of lichen-like symbiosis in 600-million-year-old fossils from South China. The previous earliest evidence of lichen was 400 million years old, discovered in Scotland. The discovery also adds to the scarce fossil record of fungi and raises new questions about lichen evolution. Xunlai Yuan, a paleontologist with the Nanjing Ins...

Researchers find first evidence of venom system in extinct mammal

A tiny fossil found more than 10 years ago in central Alberta has proved to be the key to answering a long unsolved evolutionary question, say researchers from the University of Alberta. Back in 1991, Dr. Richard Fox and his research team found a 60 million year-old incomplete skull fossil that they now believe is the first evidence of an extinct mammal with a venom delivery apparatus. Th...

Scientists find evidence of catastrophic sand avalanches, sea level changes in Gulf of Mexico

Identical twins lose some fundamental similarities as they grow older, a new study reports. Researchers report in this week's Proceedings of the National Academy of Sciences that these differences may stem from changes in the epigeno...

More>>

Evidence at Biology Products

No data found

Search Evidence biology products at Google

Search Evidence biology products at Yahoo

Search Evidence biology products at Msn

Evidence at Biology Technology

What patients want: A story of choice, clinical trials & evidence-based medicine

What is less obvious is that c...

Evidence at Medicine News

Evidence Links Protein Damage to Neurodegenerative diseases like Parkinson's and Alzheimer's

Neurodegenerative diseases - including Parkinson's, Alzheimer's, Diffuse Lewy body disease, and Multiple System Arophy - are collectively called synucleinopathies. Most commonly they become symptomatic due to a deficiency of a specific neurotransmitter - in the case of Parkinson's it is dopamine. When the neurons that produce these chemicals die or become impaired, which occurs with oxidation, th...

Breast cancer evidence

New evidence has emerged to support claims that women who work nightshifts are more prone to develop breast cancer. Research carried out in America found that women who regularly worked during the nights for up to three years were 45% more likely to develop breast cancer than those who did not work at night. And the risk increased to 65% for those who regularly worked nightshifts for more t...

Evidence supporting H.pylori eradication

A study of patients on long-term non-steroidal anti-inflammatory drug (NSAID) treatment has shown that eradication of Helicobacter pylori infection can substantially reduce the risk of ulcer formation.// Treatment with omeprazole triple therapy eradicated 90 per cent of H.pylori infections and reduced the six-month ulcer probability of 34 per cent found in the control group to 12 per cent in the...

Evidence against use of Beta blockers as first choice in the treatment of primary hypertension

Beta blockers have been used widely in the treatment of hypertension and are still recommended as first-line drugs in hypertension guidelines. Moreover, after myocardial infarction and in patients with heart failure, treatment // with beta blockers prevents re-infarction, hospitalisation for heart failure, and premature death. However, a preliminary analysis has shown that atenolol is not very ef...

Evidences that Better Health Care Facility is Offered By Public Hospitals.

In Canada questions have arisen about the best approach whether it is public or private for healthcare. The evidences point out to be that more people want public services offering better health care facilities. // In Britain the London’s public Queen Elizabeth Hospital is an example financial difficulty due to public-private partnership (P3s). In the US a study reveals that...

More>>

Evidence at Medicine Products

Drugs of Abuse Array Evidence Opiates Assay

Description:Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Company:Randox Laboratories Ltd.

Drugs of Abuse Array Evidence Methodone Assay

Description:Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Company:Randox Laboratories Ltd.

Drugs of Abuse Array Evidence Ampphetimine Assay

Description:Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Company:Randox Laboratories Ltd.

Drugs of Abuse Array Evidence Barbiturates Assay

Description:Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Company:Randox Laboratories Ltd.

Drugs of Abuse Array Evidence Ampphetimine

Description:Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Company:Randox Laboratories Ltd.

More>>

Evidence at Medicine Technology

Hemispherx Presents Evidence of Ampligen Synergies with Existing Antivirals at International Avian Influenza Conference

PARIS--(BUSINESS WIRE)--Jun 4, 2007 - Hemispherx Biopharma, Inc.(AMEX: HEB), a biopharmaceutical company engaged in the clinicaldevelopment of new drug entities for the treatment of pandemicdisease threats, announced today a new scientific report on theactivity of its experimental therapeutic Ampligen(R) in combinationwith approved anti-influenza agents against highly pathogenic avianinflue...

Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD

SEATTLE--(BUSINESS WIRE)--May 29, 2007 - Mitopharm Corporation,Inc. (Pink Sheets:MTPM), releases the results of a research paperwhere Professor Dr. Robert Ko published the beneficial effects ofSchisandrin B, the precursor of (-) Schisandrin B - a noveldiscovery by Dr. Ko - on Ischemic Heart Disease. In a research paper entitled "SCHISANDRIN B PROTECTS AGAINSTMYOCARDIAL ISCHEMIA-REPERFUSIO...

Evidence of Nanoparticles Found in Plaque-Filled Arteries

ROCHESTER, Minn., April 30. 2007-- Scientific evidenceincreasingly links arterial calcification to the presence ofnanosized particles -- so small that some scientists questionwhether a nanoparticle can live and, if so, play a viable role incausing disease. A new Mayo Clinic study cites evidence showing the presence ofnanoparticles near plaque-filled arteries in animal models....

Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers

- Journal of Clinical Oncology publishes first clinical study ofHGS-ETR1 - ROCKVILLE, Md., April 27, 2007 /PRNewswire-FirstCall/ -- HumanGenome Sciences, Inc. today reported that clinical and preclinicalevidence continues to emerge demonstrating that its TRAIL receptorantibodies, HGS-ETR1 (mapatumumab) and HGS-ETR2 (lexatumumab), havesignificant potential for use in the treatment of a bro...

Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response

LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis BioScience,Inc. (NASDAQ:ABBI), an integrated, global biopharmaceuticalcompany, discussed results from two pre-clinical studies thatprovide evidence for chemotherapy induced angiogenesis andrationale for combining nab-paclitaxel (ABRAXANE(R) for InjectableSuspension (paclitaxel protein-bound particles for injectablesuspension) (albumin-bou...

More>>